Faculty of Medicine, Universitas Indonesia, via Infectious Diseases and Immunology Recearch Center (IDIRC) Cluster IMERI FMUI, organized a public lecture on Monday, 25 March 2019, in Teaching Theater, IMERI FMUI Building, Salemba, Jakarta.
The speaker for the event is a tuberculosis (TB) vaccine expert as well as the director of Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health, and Nutrition (NIBIOHN), Jepang, Prof. Yasuhiro Yasutomi, DVM, PhD.
The lecture started at 01.30 PM, with Dr. Suwarti, STP, M.Si, Post Doctoral Research Fellow Eijkman-Oxford Clinical Research Unit (EOCRU), as the moderator. At the event, Prof. Yasuhiro explained about ““Two-Types of Novel TB Vaccine.”
Through his explanation, Prof. Yasuhiro who is also an associate professor at Mie University Graduate School of Medicine mentioned that there were two types of TB vaccines currently being developed by the Tsukuba Primate Research Center, NIBIOHN, which are the recombinant BCG vaccine and TB antigens with parainfluenza virus vector.
Recombinant BCG vaccine is specifically designed for immunocompromised people (people with a low immune system), but still effective against TB. Meanwhile, the TB antigen vaccine with parainfluenza virus vector is designed for a mucosa-induced vaccine with a strong virus as the adjuvant.
The guest lecture session then closed with a discussion and a group photo. As one of the best medical faculties in Indonesia, FMUI has a role and responsibility to improve the development of knowledge in the health industry.
The development of knowledge becomes an important issue to be shared among educators, researchers and students. Through this guest lecture, it is expected to be a platform for sharing knowledge among FMUI academicians.
(Public Relations FMUI)